We Work for Health | Washington

10/19/2026

"Price controls in Europe have coincided with a gradual contraction of the continent’s biotech sector and more limited patient access to new medicines. Policymakers must approach any similar policy shift here clear-eyed about the potential trade-offs."

https://www.nationalreview.com/2026/10/america-can-lower-drug-costs-without-sacrificing-medical-innovation/amp/

10/16/2026

American protections ensure the U.S. leads in life sciences.

A new We Work for Health blog details how help America turn ideas into breakthroughs:

Nearly 250 years ago, the United States made a consequential decision about how it would compete, grow and lead. At the nation’s founding was a belief that protecting new ideas would do more than reward individual ingenuity. It would fuel economic growth, encourage risk-taking, and help transform ...

10/14/2026

"would not fix coverage denials, insurance delays, or high out-of-pocket costs. Nor would it guarantee that lower prices reach patients at the pharmacy counter."

https://www.realclearhealth.com/articles/2026/09/25/two_kidney_transplants_what_mfn_means_for_my_third_1208271.html

10/12/2026

"If China becomes the global biotech leader, it will give Beijing significant leverage over America’s health and security in future crises. It’ll also weaken America’s ability to shape the future of medicine, profoundly damaging our economy."

https://www.statnews.com/2026/09/30/china-america-biotech-race-security/

10/09/2026

"Insurers rigged the system, counting billions in overhead, marketing and other costs as ‘medical’ expenses. We need real transparency to make sure health dollars go to patients — not just insurers’ bottom line."

https://dailycaller.com/2026/09/17/insurers-american-consumers-spend-medical-care-loss-ratio-iwc/

10/07/2026

"The lesson from the and other countries around the world is simple: Government drug price controls do not improve patient access. In many cases, price controls create incentives to ration care and empower government bureaucrats at the expense of patients."

Critics argue that the Inflation Reduction Act is increasing costs and reducing patient access to medications through price negotiations and Medicare Part D restructuring.

10/05/2026

"Drawing on nearly three decades of AUTM licensing survey data, the report finds that Bayh-Dole-enabled technology transfer has helped launch more than 19,000 startups and 17,000 new products."

More in the newly released report:https://bayhdolecoalition.org/wp-content/uploads/2026/09/The-Economic-Impact-of-the-Bayh-Dole-Act-Report.pdf

10/02/2026

"If genuinely wants disinfecting sunlight in the health care system, I’d welcome it — starting at the company’s headquarters. Let’s see sunlight on how UnitedHealth’s QPA calculations have compared to actual contracted rates."
https://healthcareuncovered.substack.com/p/unitedhealth-wants-to-shine-sunlight

09/30/2026

" Group brought in $447bn in 2025, making it the third-highest company by revenue in the US behind Walmart and Amazon and ahead of Apple."

Week Tonight with John Oliver details how profits are often put over wellbeing:

Ahead of Luigi Mangione’s sentencing, the Last Week Tonight host looked into the corporate healthcare behemoth that is UnitedHealth Group

09/28/2026

"83% of likely voters live in a household where someone regularly takes a prescription medicine. 32% said an insurance company has denied them or a family member coverage for a prescription drug."

It's time to protect : https://steptherapy.com/blog/national-survey-of-likely-voters/